Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs ; volume:31 ; number:7 ; day:12 ; month:6 ; year:2017 ; pages:585-602 ; date:7.2017
CNS drugs ; 31, Heft 7 (12.6.2017), 585-602, 7.2017
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Jongen, Peter Joseph
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-017-0444-x
- URN
-
urn:nbn:de:1111-201708035488
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jongen, Peter Joseph
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current Disease-Modifying Therapies in Multiple Sclerosis
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Current Disease-Modifying Therapies in Multiple Sclerosis
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Current Disease-Modifying Therapies in Multiple Sclerosis
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies